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A B S T R A CT  
COVID-19 also known as Novel Corona Virus Pneumonia, is a viral disease caused by novel corona 
virus. The infection is highly contagious in nature and spread from person to person through 
respiratory droplets. According to Unani System of Medicine, epidemiology and clinical features of 
COVID-19 like fever, cough, tiredness, sore throat, running nose, nasal congestion, difficulty in 
breathing etc are similar to Nazla-e-wabai (Epidemic Influenza) up to a great extent.On the basis of 
fundamental approach for living a healthy lifestyle and preventive measures during epidemic spread 
mentioned in classical  Unani texts, some standard operating procedures (SOPs)  are suggested for 
prophylactic and curative purpose in the management of COVID-19 pandemic. 
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1 Introduction 
COVID-19 also known as Novel Corona Virus Pneumonia, is a viral disease caused by SARS-CoV-2 [1]. 
It is an infectious disease and highly contagious in the nature and produce the Severe Acute Respiratory 
Distress Syndrome (SARS) [1]. It was first identified in December 2019 in Wuhan (China) so 
nomenclated as COVID-19. First case was seen in Wuhan city of China, sooner it spread as pandemic in 
all Asian and European countries. World Health Organization (WHO) declared it as a public medical 
emergency under International Health Regulations 2005 (IHR 2005) [2,3]. The infection is highly 
contagious in nature which spread from person to person through respiratory droplets.Causative agent is 
virulent enough and mutagenic in nature, unfortunately there is no sure shot treatment, so the only left 
option is prevention.Hence need was felt to review Unani literature for preventive measures. Present 
paper is tiny effort to elaborate Unani concept to provide some standard operating procedures which may 
be beneficial in prophylactic as well as remedial approach for this global health issue. 
On searching classical Unani texts, it was noticed that prophylactic approach during epidemics and 
management described under the heading of Nazla-e-Wabai are similar to COVID-19 symptomatology 
upto a great extent.  
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2 Observation & Discussion 
 Epidemiology and Pathogenesis 
COVID-19 infection is highly contagious in nature and spread from person to person through respiratory 
droplets, but sometimes it may be transmitted as airborne infection with usual onset within 2-14 days of 
exposure (on average 5th day). As far as infectivity is concerned this novel corona virus can be transmitted 
prior to the development of symptoms and throughout the course of illness and how long a person 
remains infectious is uncertain. As duration of viral shedding is variable and depend upon the severity of 
illness, the median duration of viral RNA shedding from naso– or-oropharyngeal swab is 24 days [2,4]. 
Clinical manifestations and autopsy studies suggests that the virus is highly mutagenic and different 
pathogenic potential is attributed its strain specific capacity to replicate and to cope with immune 
response of host body which behaves differently towards a viral challenge [1]. Viral infection is capable to 
produce an excessive immune reaction in the host which is called as cytokinin storm and produce the 
pro-inflammatory cytokines including IL2, IL7, IL10, MCP1, MCP1alfa, TNFalfa reasoned to promote 
severity [5,6]. The histological finding showed the classical picture of diffuse alveolar damage (DAD), 
such as hyaline membrane formation, fibrin exudates, vascular congestion, epithelial damage, and diffuse 
type II pneumocyte hyperplasia.In advance stage mild thickening of alveolar wall is seen. X-ray shows 
GGO suggestive of early exudative phase of COVID-19 pneumonia. Evidence of consolidation with 
abundant intra alveolar neutrophilic infiltration with bronchopneumonia and superimposed bacterial 
infection also seen in some cases. Some non-specific histologic changes such as proteinous exudates, 
hyperplastic pneumocytes, patchy inflammation and multinucleated giant cells also evidenced by studies 
[1, 5-8]. Stepwise demonstration of pathogenic events is shown in flowchart Figure 1.  
 Clinical Features 
Affected patients may be asymptomatic or may have mild to moderate clinical manifestations of Acute 
Respiratory Distress Syndrome (ARDS) depends upon virulency, host immunity and associated comorbid 
conditions like diabetes mellitus, hypertension, cancer etc. In mild cases Common symptoms are Fever, 
Headache, Sore throat, Nasal congestion, Runny nose, Dry cough, Tiredness etc. Some people 
experience, Cough with sputum, Anosmia, Loss of taste, Vomiting, Diarrhea etc., whereas Shortness of 
Breath, Tachypnea, Hypoxia and Hypotension are seen in moderate to severe cases as ARDS [9-13]. 
 Unani perspective for COVID-19 
As it is evident that COVID -19 has emerged as a new disease so there is no literature available as such in 
unani system of medicine, but the signs and symptoms given under Nazla-e-Wabai (Epidemic Influenza) 
such as fever, cough, tiredness, sore throat, running nose, nasal congestion, difficulty in breathing etc are 
similar to clinical features of COVID-19  up to a great extent [14,15]. 
Unani fundamental of treatment during epidemic/pandemic (waba) is to maintain equilibrium in Asbaab 
sitta zaruriya (six essential factors), Immunomodulation and protection of vital organs functions following 
isolation and quarantine strategy apart and symptomatic approach as per patient profile [16].  Preventive 
measures explained by eminent Unani scholars during contagious diseases are [17,18]: 
• Abatoon (Isolation) of patient. 
• Avoid contact with infected person (Social distancing) 
• Avoid dryness of mouth, take lukewarm water & perform gargle frequently. 
• Use of balanced nutritional diet like Ma-al-shaeer (Barley water) and avoid non vegetarian diet.  
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 Plan for SOPs 
Unani treatment is based on three modalities- 
1. Ilaj-bil-Tadbeer (Regimenal therapy), 2. Ilaj-bil-Dawa (pharmaco therapy), 3. Ilaj-bil-Yad (Surgery) 
As it is evident from various studies that COVID-19 clinically causes pneumonia with destruction of 
alveolar tissue & formation of fibrinoid membrane in intra alveolar space with hemorrhage leads to severe 
respiratory distress. Metabolic changes in response to viral toxins leads to partial or severe damage to 
various body organs causes failure and death due to multiorgan dysfunction syndrome (MODS) [5-8]. So, 
the line of treatment may be designed by keeping following points: 
• Minimise alveolar destruction and lungs parenchyma due to inflammation. 
• Patency of airways by removal of cellular debris from alveolar spaces. 
• Minimise the lung consolidation and improve lung functions. 
• Prevention of vital organ dysfunction by toxic and metabolic disturbances. 
• All channels of viral shedding must be checked in order to prevent spread of infection. 
• Appropriate dietotherapy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow chart showing pathogenesis of COVID-19 [5] 
In above regard following Unani Medicines are suggested in order to expel out morbid matters from the 
body and to protect vital organ functions, hence may be beneficial for the treatment of Corona virus 
Death due to complications and effects caused by 
Cytokinin Storm Syndrome 
Severe Acute Respiratory Distress Syndrome (SARS) 
Fulminant Myocarclits (Cardiac affinity) 
 
Alteration of DNA and protein synthesis of affected 
cell with production of certain enzymes 
 
Alteration of cell function and production 
Release of enzymes, cytokins, chemokimin 
(IL-1β, IL-6, IL-7, 1L-8, 9-10,) TNFα 
 
Acute Phase Reaction {ESR ↑ed.} 
{CRP- ↑ed.} 
{Procalcitonin ↑ed.} 
Virus attached to specific cellular receptors in nasal 
cavity with the help of specific glycoproteins 
 
Transformational changes, leading to fusion between 
the virus and cell membrane. 
 
Release of nucleocupsid into the cell transcription and 
translation. 
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disease (COVID-19) for mild to moderate illness at home as mentioned in classical Unani literature for 
Nazla-e-Wabai (epidemic influenza).  
• Anti inflammatory, Antipyretic, Antiviral/ Antiseptic. 
• Antitussive, Mucolytic, Expectorant. 
• Deobstruent and vasoprotective/Heamoprotective. 
• Immunomodulator and vital organs protective. 
• Tranquilizers/ Mood elevators, Antipsychotic. 
• Hepato protective and intestinal modulators.  
 
On behalf of above explained parameters of management profile in COVID-19 and related clinical 
problems, some important unani single drugs as well as compound formulations (Table 1 and 2) 
andappropriate interventions are mentioned below  
 
Table 1: Some important Unani drugs and their related pharmacological actions. 
S.No. Therapeutic peculiarity Unani Single Drugs 
1 Muhallil (Anti-inflammatory, resolvant), 
Mulattif (Mucolytic), Mugharri (Soothing), 
Mukhrij (Expectorant) [16,19,20] 
Sapista (Cordia myxa), Unnab (Ziziphus sativa), 
ZufaKhushk (Hyssopus officinalis), Asal-us-Sus 
(Glycyrrhiza glabra), Baadiyan (Foeniculum 
vulgare), Rehan/Tulsi(Ocimum sanctum),Giloy 
(Tinosporacordifolia), Aspghol (Pantago ovata) 
 
 
 
2 
 
 
Mufatteh (Deobstruent)[19, 20, 21] 
Zarneekh (Arsenic trisulfide/ Arsenic disulfide), 
Honey, Ustu-khuddus (Levendulastoechas), Zufa 
Khushk (Hyssopus officinalis),Asal-us-Sus 
(Glycyrrhiza glabra), Baadiyan (Foeniculum 
vulgare), Afsanteen (Artemisia absinthium) 
 
 
 
3 
 
Deobstruent and 
Vasoprotective/Heamoprotective[19-23] 
Honey, Kushta e Hartaal, Kushta Qarnulayyal, 
Kushta Godanti, Sikanjbeen, Donkey milk etc. 
may prove to be beneficial in bleeding diathesis 
in this disease. 
 
4 Immunomodulator and vital organs 
protective [16, 24, 25] 
Rehan/Tulsi (Ocimum sanctum), 
Giloy (Tinosporacordifolia),  
Asgandh (Withaniasomnifera), Donkey Milk 
5 Mufarrih (Exhilarant), Musakkinaat 
(Relaxant, Antianxiety), Antipsychotic 
[19] 
Abresham (Bombyx mori),  
Gul Surkh (Rosa damascena),  
Ustukhuddus (Levendulastoechas),  
Gaozaban (Onosmabracteatum),  
Rehan/Tulsi (Ocimum sanctum),  
Banafsha (Viola odorata) 
6 Hepato protective and intestinal 
modulators [20] 
Afsanteen (Artemisia absinthium). Honey 
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Table 2: Some compound Unani formulations for symptomatic relief [15,16,22]: 
S.No. Therapeutic 
peculiarity 
Unani Drugs and Dosage 
 
 
1 
 
 
For Cough 
Habb-e-Surfa 02-02 tablet thrice a day.  
Sharbat-e-Unnab 25ml with Lukewarm water, every 8 hourly. 
Sharbat-e-Zoofa Murakkab 25ml with Lukewarm water, every 8 hourly. 
Lauq-e-Sapistan 5-10gm with Lukewarm water, every 8 hourly. 
2 For Fever Habb-e-Mubarak 02-02 tablet twice a day or thrice a day.  
Sharbat-e-Khaksi 25ml with Lukewarm water, every 8 hourly. 
3 As antidote Tiryaq-e-Arba 5gm, twice a day. 
4 For rhinorrhea Tiryaq-e-Nazla 5gm, twice a day. 
5  
Immunobooster 
Habb-e- Asgand 02 tablet twice a day or thrice a day 
Khameera Marwareeed 10gm before breakfast. 
Khamira Abresham Sheera Unnab Wala,  
Arq e Ajeeb etc. 
 
 Some Unani Interventions (Nuskha) 
Intervention-1 
1. Khamira Aabresham Sheera Unnab Wala (5gm)  
+ Qurs Kushta Qarnul Ayyel (1Tablet or 125 mg) 
 
In morning 
2. Sharbat-e-Zoofa Murakkab (20 ml) Twice a day 
3. Lauq Sapistan Khiareshamber (10 gm) 
                      or 
[Lauq Katan (10 gm) + Habb-e-Jadwar (1 pill)] 
                     or 
Qurs Kushta Gaudanti (1 Tablet/120 mg) 
 
 
In the evening 
4 Plenty of Maa-al-Asl (Honey water) in sufficient quantity.  
Intervention -2 
1. [Khamira Gauzuban Ambri Jawahar Wala (10 gm) + Qurs 
Kushta Hartal (1 Tablet or 125 mg)]  
or 
[Khamira Gauzuban Ambri Jawahar Wala (10 gm)  
+ Qurs Kushta Gaudanti (1 Tablet or 125 mg)] 
 
In morning 
2. Sharbat-e-Aijaaz (20 ml)  Twice a day 
3. Khameera Banafsha (10 gm) + 
Qurs Kushta Marjaan (1 Tablet or 125 mg) 
In the evening 
Intervention -3 
1. [Khameera Marwareed Khas (7 gm) +  
Qurs Kushta Hartal (1 Tablet or 125 mg)]  
In morning 
2. Sualeen4 Tablet (Decoction) Twice a day 
3. Safoof Kakda Singhi (1 gm) + 
Asl e Khalis (Pure honey5 ml) 
In the evening 
4 Plenty of Maa-al-Asl (Honey water) in sufficient quantity  
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 Dietary recommendations 
• Diet should be light, frequent and easy to digest. 
• Avoid processed food, carbonated drinks, and junk foods as much as possible. 
• Rehydrate bodywith lukewarm waterat frequent intervals, vinegar can be added to make it more 
beneficial during epidemic/pandemic [19,20]. 
• Honey and coffee paste added with lukewarm water is effective against irritating cough.[26]. 
• Maa’ulasal (Honey water) [19, 23], Maa’ulshaeer (Barley water) [20, 23]. These medicines not only 
rehydrate body but also provide nutrition and expel out morbid matters from the body. 
• Donkey milk 250ml is effectivein all types of lung ailments, very good immunomodulator and 
healing agent [20, 27]. 
 Regimenal Approach 
For prophylactic and curative purpose and to prevent spread of infection, all the channels of viral 
shedding must be checked. For this purpose, the following regimens may be applied. 
(i) Nasal Route:  
• Local application of Roghan e Banafsha (oil of Viola odorata)/ Roghan e Kaddu (Cucurbita 
pepo)/ Human milk in both nostrils [20]. 
• Sniffing of Kalonji (Nigella sativa) powder mixed with olive oil 3 times a day [28]. 
• Inhalation of Arq-e-Ajeeb2-5 drops [16,24]. 
• Kafoor (Camphor) and Sandal (Santalum album) in the form of pouch can be tied in theneck 
and/smelled frequently [16, 24]. 
(ii) For ophthalmic Route: Rose water, Burud-e-Kafoorimay be applied in both eyes [22,24]. 
(iii) Oropharyngeal Route: Gargle with salt water, khiyareshambar (Cassia fistula), Guava leaves 
(Psidium guajava) Honey based ginger (Zingiber officinale) and Asal-us-Sus (Glycyrrhiza glabra) 
lozenges can be prepared for licking [16,23,29]. 
(iv) Gastrointestinal Route: 
• Herbal tea prepared from ginger (Zingiber officinale), turmeric (Curcuma longa), kalonji, honey 
and lemon may be consumed 2- 3 times a day [16, 19, 24]. 
• Freshly prepared green paste (chatni) of green coriander (Coriandrum sativum)/green mint 
(Mentha), green chillies (Capsicum annum), cumin (Cuminumcyminum), garlic (Alium sativa), salt, 
lemon/vinegar can be consumed with food helps digestion and cleansing the bowel and may 
improve intestinal immunity. 
• Appropriate disposal of patient’s levateries by using disinfectants and bleeching agents etc. 
 Conditioning of Patient’s place:  
• Sprinkle Arq e Gulab (Rose water), 4 times in and around patient’s room [20, 23]. 
• Fumigation of Camphor, Loban (Styrax benzoin), ood (Agarwood), Muqil (Commiphorawightii) etc.  
• Fencing or curtains prepared from Neem (Azadirechtaindica) leaves, Rose petals, Barg-e-Hina 
(Lawsoniainermis), Khas (Chrysopogonzizanioides)etc [20, 23]. 
• As antiseptic cooler fragrance, Neem (Azadirechtaindica) leaves decoction, camphor, Arq-e-Gulab 
(Rose water), Arq-e-kewda (Pandanus odorifer), Arq-e-Ajeeb can be poured in water [20, 23]. 
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 General Measures 
• Maintenance of social distancing, cough and sneezing etiquettes.  
• Use of face mask and frequent hand hygiene must be followed. 
• Yoga and breathing exercises on daily basis. 
3 Conclusion 
Non availability of any effective anti COVID-19 medicine poses a great challenge to the world 
population. Since this disease is new and not mentioned in any literature but keeping in view of the 
mentioned features and disease spread of Nazla-e-Wabaii in ancient unani literature which are very similar 
to COVID-19, it will be wise to evaluate these time tested guidelines and treatment approaches with 
either no or least harmful effects for their possible prophylactic and curative (singly or as an adjuvant to 
conventional medicine) role.We believe that these mentioned approaches will provide a suitable platform 
for the researchers to plan scientific studies on them and any promising result might help the ailing 
mankind throughout the globe. 
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